SCHAUL ROBERT F 4
4 · NOVADEL PHARMA INC · Filed Jun 21, 2004
Insider Transaction Report
Form 4
SCHAUL ROBERT F
Director
Transactions
- Award
Stock Option
[F2]2004-05-06+50,000→ 50,000 totalExercise: $1.95Exp: 2009-04-18→ Common Stock (50,000 underlying)
Holdings
- 39,286
Common Stock
- 20,000
Stock Option
[F1]Exercise: $0.63Exp: 2006-07-31→ Common Stock (20,000 underlying) - 25,000
Stock Option
[F1]Exercise: $0.63Exp: 2008-03-31→ Common Stock (25,000 underlying) - 10,000
Stock Option
[F1]Exercise: $0.63Exp: 2009-09-30→ Common Stock (10,000 underlying) - 95,000
Stock Option
[F1]Exercise: $0.63Exp: 2010-01-31→ Common Stock (95,000 underlying) - 75,000
Stock Option
[F1]Exercise: $2.69Exp: 2012-02-14→ Common Stock (75,000 underlying) - 10,000
Stock Option
[F1]Exercise: $1.51Exp: 2008-03-27→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Information has been previously filed with the Securities and Exchange Commission.
- [F2]The options vest in three annual installments. 16,666 options become exercisable on April 19, 2005, 16,666 become exercisable on April 19, 2006 and 16,667 become exercisable on April 19, 2007.
Signature
/s/ Robert F. Schaul|2004-05-21